Zabala-Letona, AmaiaArruabarrena-Aristorena, AmaiaMartín-Martín, NataliaFernandez-Ruiz, SoniaSutherland, James DClasquin, MichelleTomas-Cortazar, JulenJimenez, JoseTorres, InesQuang, PhongXimenez-Embun, PilarBago, RuzicaUgalde-Olano, AitziberLoizaga-Iriarte, AnaLacasa-Viscasillas, IsabelUnda, MiguelTorrano, VerónicaCabrera, Dianavan Liempd, Sebastiaan MCendon, YleniaCastro, ElenaMurray, StuartRevandkar, AjinkyaAlimonti, AndreaZhang, YinanBarnett, AmeliaLein, GinaPirman, DavidCortazar, Ana RArreal, LeirePrudkin, LudmilaAstobiza, IanireValcarcel-Jimenez, LoreaZuñiga-García, PatriciaFernandez-Dominguez, ItziarPiva, MarcoCaro-Maldonado, AlfredoSánchez-Mosquera, PilarCastillo-Martín, MireiaSerra, VioletaBeraza, NaiaraGentilella, AntonioThomas, GeorgeAzkargorta, MikelElortza, FelixFarràs, RosaOlmos, DavidEfeyan, AlejoAnguita, JuanMuñoz, JavierFalcón-Pérez, Juan MBarrio, RosaMacarulla, TeresaMato, Jose MMartinez-Chantar, Maria LCordon-Cardo, CarlosAransay, Ana MMarks, KevinBaselga, JoséTabernero, JosepNuciforo, PaoloManning, Brendan DMarjon, KatyaCarracedo, Arkaitz2023-01-252023-01-252017-06-28http://hdl.handle.net/10668/11354Activation of the PTEN-PI3K-mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation. Here we show that mechanistic target of rapamycin complex 1 (mTORC1) regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. By using integrative metabolomics in a mouse model and human biopsies of prostate cancer, we identify alterations in tumours affecting the production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis. Mechanistically, this metabolic rewiring stems from mTORC1-dependent regulation of S-adenosylmethionine decarboxylase 1 (AMD1) stability. This novel molecular regulation is validated in mouse and human cancer specimens. AMD1 is upregulated in human prostate cancer with activated mTORC1. Conversely, samples from a clinical trial with the mTORC1 inhibitor everolimus exhibit a predominant decrease in AMD1 immunoreactivity that is associated with a decrease in proliferation, in line with the requirement of dcSAM production for oncogenicity. These findings provide fundamental information about the complex regulatory landscape controlled by mTORC1 to integrate and translate growth signals into an oncogenic metabolic program.enCC0 1.0 Universalhttp://creativecommons.org/publicdomain/zero/1.0/Adenosylmethionine DecarboxylaseAnimalsCell ProliferationEnzyme ActivationEverolimusHumansMaleMechanistic Target of Rapamycin Complex 1MetabolomicsMiceMultiprotein ComplexesPTEN PhosphohydrolasePhosphatidylinositol 3-KinasesPolyaminesProstatic NeoplasmsProtein StabilityS-AdenosylmethionineTOR Serine-Threonine Kinasesresearch article28658205open access10.1038/nature229641476-4687PMC5505479https://ddd.uab.cat/pub/artpub/2017/pmc_28658205/pmc_28658205.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505479/pdf